1. From Incidence to Intervention: A Comprehensive Look at Breast Cancer in South Africa

   • Zodwa Dlamini
   • Thulo Molefi
   • Rodney Hull

   Editorial Open access 01 November 2023 Pages: 1 - 11

   

2. Is HER2-Low a New Clinical Entity or Merely a Biomarker for an Antibody Drug Conjugate?

   • Heidi Ko
   • Rebecca A. Previs
   • Kamal S. Saini

   Editorial Open access 14 November 2023 Pages: 13 - 17

3. Adjuvant CDK4/6 Inhibitors for Early Breast Cancer: How to Choose Wisely?

   • Elisa Agostinetto
   • Luca Arecco
   • Evandro de Azambuja

   Commentary Open access 21 November 2023 Pages: 19 - 29

   

4. Intratumoral Injection of Large Surface Area Microparticle Taxanes in Carcinomas Increases Immune Effector Cell Concentrations, Checkpoint Expression, and Synergy with Checkpoint Inhibitors: A Review of Preclinical and Clinical Studies

   • Gere S. diZerega
   • Holly A. Maulhardt
   • Marc A. Iacobucci

   Review Open access 30 January 2024 Pages: 31 - 55

   

5. Small Molecule Menin Inhibitors: Novel Therapeutic Agents Targeting Acute Myeloid Leukemia with KMT2A Rearrangement or NPM1 Mutation

   • Xavier Thomas

   Review Open access 01 February 2024 Pages: 57 - 72

   

6. Non-Small Cell Lung Cancer Testing on Reference Specimens: An Italian Multicenter Experience

   • Francesco Pepe
   • Gianluca Russo
   • Giancarlo Troncone

   Original Research Open access 11 January 2024 Pages: 73 - 95

   

7. Experiences and Support Needs of Caregivers of Patients with Higher-Risk Myelodysplastic Syndrome via Online Bulletin Board in the USA, Canada and UK

   • Pauline Frank
   • Anne Olshan
   • Emma Sasse

   Original Research Open access 07 December 2023 Pages: 97 - 114

   

8. Diversity in Oncology Clinical Trials: Current Landscape for Industry-Sponsored Clinical Trials in Asia

   • Dany Habr
   • Manmohan Singh
   • Roberto Uehara

   Original Research Open access 08 December 2023 Pages: 115 - 129

   

9. Patient Versus Physician Perspective in the Management of Chronic Myeloid Leukemia During Treatment with Tyrosine Kinase Inhibitors

   • Hong Chen
   • Yan Wen
   • Na Xu

   Original Research Open access 16 December 2023 Pages: 131 - 145

   

10. A Retrospective Study of Cemiplimab Effectiveness in Elderly Patients with Squamous Cell Carcinoma of the Skin: Insights from a Real-Life Scenario

    • Giuseppe Di Lorenzo
    • Aieta Michele
    • Carlo Buonerba

    Original Research Open access 19 December 2023 Pages: 147 - 155

    

11. Acute Thrombocytopenia Complicating the Initial Administration of Obinutuzumab: Is It More Frequent Than We Think?

    • Umut Yılmaz
    • Selin Küçükyurt
    • Ahmet Emre Eşkazan

    Case Series Open access 22 January 2024 Pages: 157 - 161

    

12. Repotrectinib’s Clinical Benefit and Its Brain Penetration in a Patient with Meningeal Carcinomatosis from G2032R-Mutated ROS-1 Positive Non-Small Cell Lung Cancer

    • Giulio Metro
    • Eleonora Gariazzo
    • Gianluigi Lunardi

    Case Report Open access 16 November 2023 Pages: 163 - 171

    

13. Correction: Repotrectinib’s Clinical Benefit and Its Brain Penetration in a Patient with Meningeal Carcinomatosis from G2032R-Mutated ROS-1 Positive Non-Small Cell Lung Cancer

    • Giulio Metro
    • Eleonora Gariazzo
    • Gianluigi Lunardi

    Correction Open access 03 January 2024 Pages: 173 - 174

14. Long-Term Survival and Stable Disease in a Patient with Extensive-Stage Small-Cell Lung Cancer after Treatment with Carboplatin, Etoposide and Atezolizumab

    • Reyes Bernabé
    • Stephen V. Liu
    • Miriam Alonso García

    Case Report Open access 27 January 2024 Pages: 175 - 182

    

15. Long Term Remission of Capillary Leak Syndrome Associated with Monoclonal Gammopathy with Progression to Multiple Myeloma After Autologous Stem Cell Transplantation: a Case Report and Review of the Literature

    • Gerardo Hermida
    • Rodolfo Alvarez-Nuño
    • Tomás José González-López

    Case Report Open access 02 February 2024 Pages: 183 - 188